How do I diagnose and treat prostate issues, including BPH and prostate cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Order and Interpret Prostate Ultrasound

Order transabdominal ultrasound when a patient has selected minimally invasive or surgical intervention for BPH, requesting measurement of prostate volume, post-void residual (PVR), intravesical prostatic protrusion (IPP) grade, and identification of intravesical lobes. 1

When Ultrasound Is NOT Indicated

Do not order prostate ultrasound for:

  • Initial evaluation before starting watchful waiting 1
  • Before initiating medical therapy with alpha-blockers or 5-alpha reductase inhibitors 2, 1
  • Determining "need for treatment"—symptoms and patient bother drive this decision, not anatomy 1

When Ultrasound IS Indicated

Order transabdominal or transrectal ultrasound when:

  • Patient has selected surgical or minimally invasive intervention (TURP, laser therapy, etc.) 1
  • Determining candidacy for specific surgical procedures 1
  • Assessing for intravesical lobes that impact surgical approach 1
  • Staging prostate cancer (rectal ultrasound to assess capsular and seminal vesicle involvement) 2

Essential Measurements to Request

When ordering ultrasound for BPH evaluation, specifically request:

  • Prostate volume (measured in cubic centimeters or grams) 1
  • Post-void residual (PVR) volume 1
  • Intravesical prostatic protrusion (IPP) grade 1
  • Presence of intravesical lobes (middle lobe protruding into bladder) 1
  • Anatomical features that may impact therapy choice 1

Interpreting Results

Prostate Volume

  • Prostate size alone does not determine treatment need—a man with large prostate but minimal symptoms may not require intervention, while someone with moderate enlargement but severe bother may benefit from treatment 1
  • Larger prostates (>40g) predict better response to 5-alpha reductase inhibitors like finasteride 3

Post-Void Residual (PVR)

  • Large PVR volumes (e.g., 350 mL) may indicate bladder dysfunction and predict slightly less favorable treatment response 1
  • PVR is NOT a contraindication to watchful waiting or medical therapy—many patients maintain large residual volumes without urinary tract infection, renal insufficiency, or bothersome symptoms 1
  • Do not withhold treatment based solely on elevated PVR 1

Intravesical Prostatic Protrusion (IPP)

  • IPP grading combined with prostate volume and PVR provides anatomical staging of BPH 1
  • Higher IPP grades may predict need for surgical intervention over medical management 1

Common Pitfalls to Avoid

  • Do not order ultrasound before starting alpha-blockers—symptom response to tamsulosin is not dependent on baseline prostate size 1
  • Do not use ultrasound findings alone to determine treatment—patient symptoms and bother are primary determinants 2, 1
  • Transabdominal ultrasound is preferred over cystoscopy for anatomical assessment when surgery is considered 4

Alternative to Ultrasound for Cancer Evaluation

For differentiating BPH from prostate cancer:

  • Digital rectal examination (DRE) is mandatory—soft, non-tender prostate suggests BPH; hard, nodular prostate suggests cancer 4, 5
  • PSA testing should be offered to patients with ≥10-year life expectancy 4
  • Ultrasound-guided core needle biopsy is required for pathological diagnosis of cancer 2

References

Guideline

Guidelines for Screening and Treating Benign Prostatic Hyperplasia (BPH)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differentiation of BPH and Prostate Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of Benign Prostatic Hyperplasia (BPH)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

How are elevated PSA levels managed in the context of both prostate cancer and BPH?
When should prostate cancer be suspected versus Benign Prostatic Hyperplasia (BPH)?
What are the treatment options for benign prostatic hyperplasia (BPH) or prostate cancer?
How do ultrasound findings differentiate between Benign Prostatic Hyperplasia (BPH) and prostate cancer?
What complication is a 72-year-old male with benign prostatic hyperplasia (BPH) or prostate cancer, impaired renal function, and post-obstructive diuresis at risk for after experiencing a significant increase in urine output following urinary catheterization?
What is the risk of stroke in a patient with a history of transient ischemic attack (TIA) who stopped antiplatelet therapy (aspirin) 9 months ago, has minimal extracranial stenosis with normal intracranial vessels, and now requires mastoidectomy with facial nerve decompression due to skull base osteomyelitis?
What is the appropriate initial step for a 2-month-old infant with small amounts of bright red blood in stools and no other symptoms?
What cough medication is suitable for a diabetic patient?
What are the guidelines for performing ultrasound needle fenestration for elbow pain due to conditions like tendinitis or bursitis in a patient with potential bleeding disorders or on anticoagulant therapy?
Should a 27-year-old female patient with a history of allergies, previous septoplasty (nasal septum surgery) with minimal relief, and persistent nasal breathing difficulties be referred for septorhinoplasty (surgical procedure to correct nasal septum and rhinoplasty) or tried on medical treatment for allergies first?
What is the initial treatment approach for a patient with dyspnea and a history of respiratory conditions such as asthma or Chronic Obstructive Pulmonary Disease (COPD) and potentially heart failure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.